Platelet surface physiology and its importance in pharmacotherapy design and development: the adenosine diphosphate receptor antagonists.
Becker
R C
RC
Cardiovascular Thrombosis Research Center, University of Massachusetts Medical School, Worcester, Massachusetts 01655, USA. beckerr@ummhc.org
D000244:Adenosine Diphosphate / Q000378:metabolism / Q000494:pharmacology; D001792:Blood Platelets / Q000737:chemistry / Q000502:physiology*; D015195:Drug Design; D006801:Humans; D015539:Platelet Activation / Q000187:drug effects; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D058919:Purinergic P2 Receptor Antagonists; D011956:Receptors, Cell Surface / Q000037:antagonists & inhibitors / Q000378:metabolism / Q000502:physiology; D018048:Receptors, Purinergic P2 / Q000378:metabolism / Q000502:physiology; D013927:Thrombosis / Q000188:drug therapy / Q000209:etiology
D010975:Platelet Aggregation Inhibitors; D058919:Purinergic P2 Receptor Antagonists; D011956:Receptors, Cell Surface; D018048:Receptors, Purinergic P2; D000244:Adenosine Diphosphate